Blog
Investing guides, market analysis, and financial education.

Should You Buy Oracle Corp. Stock Right Now? An Honest Look
Oracle just raised its fiscal 2026 revenue forecast to $90 billion, beating estimates — yet the stock still sold off on a financing announcement. The bull case on ORCL is real, but the valuation leaves no margin for error. Here's our verdict.
Jun 22, 2026
S&P Global (SPGI): Hidden Risks Most Investors Are Ignoring
"S&P Global trades at ~45x forward earnings — a multiple that assumes everything goes right. Between rating cycle headwinds, AI disruption risk to Market Intelligence, and a $44B acquisition still proving itself, the risks are stacking up. Here's our verdict."
Jun 22, 2026
Is iShares Semiconductor ETF (SOXX) Overvalued? A Deep Dive Into the Numbers
"SOXX just hit a new 52-week high after surging nearly 6% on Computex 2026 AI hardware catalysts — but buying at all-time highs in a sector priced for perfection is a different risk calculation than riding the wave up. Here's whether SOXX is overvalued right now and our 12-month verdict."
Jun 22, 2026
The Bull Case for Chevron Corp. in 2026 — and Why Bears Are Wrong
"Chevron stock is up 22% in 2026, yet most bears still haven't updated their models. The bull case rests on a $20B free cash flow target, Permian efficiency gains, and a LNG portfolio that prints cash regardless of crude volatility. Our verdict: BUY with a $225–$235 price target."
Jun 21, 2026
The Bull Case for RTX Corp. in 2026 — and Why Bears Are Wrong
"RTX Corp. just secured a $6.6 billion engine contract and reports earnings July 21 — yet bears keep circling. The bull case rests on surging backlog, fading GTF headwinds, and defense spending that's structurally, not cyclically, driven. Our verdict: BUY."
Jun 21, 2026
Honeywell in a Recession: How HON Holds Up When Markets Fall
"Honeywell's aerospace division just posted 28% orders growth as its spinoff receives final approval — yet recession fears keep HON undervalued. We argue the conglomerate discount is about to disappear and the pure-play aerospace story is worth $280–$300. Here's the full case."
Jun 20, 2026
What Insiders Are Saying About Duke Energy (DUK) in 2026
"Analysts have set a $117.00 consensus price target on Duke Energy (DUK) while the stock trades at a discount — a gap that insider activity and data center demand tailwinds suggest the market is misreading. Here's why DUK earns a BUY in 2026."
Jun 20, 2026
The Bear Case for Valero Energy: Red Flags Every Investor Should Know
"Valero Energy dropped 4.36% in a single session after Iran deal news crushed the geopolitical risk premium baked into the stock. With crack spreads compressing and Q2 2026 earnings due July 30, the bull case looks shaky. Our verdict: AVOID."
Jun 20, 2026
Is AbbVie (ABBV) Overvalued? A Deep Dive Into the Numbers
"AbbVie trades at just 14x forward earnings despite generating $20B+ in annual free cash flow — a discount the market may be misreading. With Skyrizi and Rinvoq outpacing the Humira transition, ABBV looks mispriced. Here's our 12-month verdict."
Jun 19, 2026
What Insiders Are Saying About Bank of America (BAC) in 2026
"Bank of America just reaffirmed its Q1 2026 dividend, signaling internal confidence the market hasn't fully priced in. Analysts expect continued EPS growth and a valuation re-rating toward peers. Our verdict: BAC is a BUY with a $55–$60 target."
Jun 19, 2026
Visa Inc. in a Recession: How V Holds Up When Markets Fall
"Visa stock is trading near $333, up 2.87% in recent sessions — and its Q2 2026 earnings on April 28 are the next major test. The case for holding V through a recession is stronger than most investors realize. Here's exactly why, and our 12-month price target."
Jun 18, 2026
The Bull Case for Lockheed Martin in 2026 — and Why Bears Are Wrong
Lockheed Martin is up 30% in 2026 — here's why the bull case is intact and why the bears are getting this one wrong.
Jun 18, 2026Morgan Stanley Price Target 2026: Where Analysts Think MS Is Headed
Morgan Stanley crushed Q1 2026 estimates with a $1B trading beat and 13.58% EPS surprise. Here's where analysts think MS stock is headed next.
Jun 17, 2026
What Insiders Are Saying About Snowflake (SNOW) in 2026
Snowflake is down 35% in 2026, but insiders and institutional buyers signal the worst may be priced in. Here's the real verdict.
Jun 17, 2026
ExxonMobil Fair Value 2026: Bull Case vs. Bear Case
ExxonMobil's fair value debate for 2026 comes down to Pioneer synergies, Guyana growth, and where oil prices land. Here's the verdict.
Jun 16, 2026
AMD in a Recession: How AMD Holds Up When Markets Fall
AMD has a beta of 2.49 and a P/E of 179 — here's exactly how it holds up when markets fall and recessions hit.
Jun 16, 2026
JPMorgan Chase Earnings Preview: What the Numbers Say About JPM
JPM trades 13% below the $342 analyst consensus — here's whether the earnings setup justifies buying the dip before Q2 results.
Jun 15, 2026
The Bull Case for Goldman Sachs in 2026 — and Why Bears Are Wrong
Goldman Sachs stock is up 51% in a year and the bull case for 2026 still holds — here's why bears are missing the real story.
Jun 15, 2026
The Bear Case for Cloudflare: Red Flags Every Investor Should Know
Cloudflare beats Q1 estimates but the stock falls anyway — here's why NET at $228 is a risk most investors are underpricing.
Jun 15, 2026
ConocoPhillips (COP): Hidden Risks Most Investors Are Ignoring
COP stock closed at $116.76 amid falling oil prices and Iran deal risk — here's why the bullish consensus may be misleading right now.
Jun 15, 2026
Mastercard Growth Story: Can MA Keep Delivering in 2026?
Mastercard beat earnings for the 20th straight quarter with Q1 2026 revenue up 15.8%. Here's why MA is still a BUY heading into the second half of 2026.
Jun 14, 2026
Should You Buy Coinbase Stock Right Now? An Honest Look
Coinbase just reported its worst quarterly performance in over a year, with Q1 2026 revenue collapsing 31% year over year to $1.4 billion as crypto trading
Jun 14, 2026
The Bear Case for Eli Lilly: Red Flags Every Investor Should Know
Eli Lilly stock is down 11% in 2026 despite record earnings. Here's the bear case bulls are ignoring before it's too late.
Jun 14, 2026
Merck Earnings Preview: What the Numbers Say About MRK
Merck posted $16.3B in Q1 2026 sales. Here's what the numbers say about MRK stock and whether it's a buy heading into a critical pipeline period.
Jun 14, 2026